RRM2 and cancer: The rationale behind this strategy also exploits the intrinsic upregulation of genes involved in dNTP biosynthesis, such as those encoding TK1, RRM2 and TS, among others, which several studies have found to be among the top metabolic enzymes frequently overexpressed in several cancer types (Irwin et al., 2017; Nilsson et al., 2014).